- Rating
- 1
- Confidence
- 4
- Informativeness
- 1
- Presentation
- 1
- Soundness
- 1
Read review
Paper summary
This paper introduces MoSPR, a lightweight framework for predicting bulk gene expression from whole-slide histopathology images. The method first clusters frozen CONCH patch embeddings into morphology “microstates”, summarizes their spatial co-occurrence through patient-level and cohort-level adjacency matrices. Each WSI is represented using a global mean feature together with abundance-weighted macrostate-specific deviations. On the molecular side, the target gene-expression matrix is projected onto a PCA-derived low-rank basis, and ridge regression maps the WSI representation to the corresponding molecular coefficients. Owing to the block-structured linear formulation, predictions can be decomposed into global and macrostate-specific contributions. The method achieves strong performance across three TCGA cohorts and shows favorable data efficiency.
Critical strengths
The method is simple, computationally efficient, and appears well suited to the relatively limited sample sizes available for paired WSI–RNA data. The experiments are reasonably comprehensive, including multiple TCGA cancer cohorts, pathway-level evaluation, training-set scaling, computational complexity, and component ablations.
Critical weaknesses
- The methodological novelty appears limited and should be positioned more carefully. Most individual components of MoSPR are well-established techniques: frozen pathology foundation-model features, k-means-based morphology prototypes, spatial patch adjacency, diffusion-map/spectral clustering, PCA-based dimensionality reduction, and ridge regression.
- The low-rank molecular component is largely standard PCA regression. The second major contribution claimed by the paper is a “training-derived low-rank expression basis”. However, the proposed procedure consists of fitting PCA to the standardized gene-expression matrix, regressing histology features onto the PCA coefficients using ridge regression, and reconstructing the output through the PCA basis.
Questions for authors
-
The manuscript suffers from substantial writing and presentation issues. Overall, it reads more like a quickly assembled technical report than a carefully polished conference paper. The abstract is poorly balanced. Roughly two-thirds of the abstract is devoted to experimental results, while the motivation, research problem, and core methodological idea receive comparatively limited explanation. The introduction lacks a clear problem-driven narrative. It should better explain why H&E-to-bulk gene expression prediction is important, what the key challenges are, and where existing methods fall short, rather than mainly presenting a sequential description of the proposed pipeline. The introduction is overly technical for its purpose. As a computational pathology paper, the introduction should emphasize motivation, challenges, intuition, and introducing detailed mathematical formulations at this stage unnecessarily hurts readability. The overall readability is weak. Many sections are written in a technical-report style, with insufficient high-level explanation and transitions between methodological components.
-
Equation (20) is poorly formatted. The block partition of the regression matrix would be clearer.
-
The Related Work section is incomplete. It does not adequately review the broader literature on H&E and bulk gene expression, including works on multimodal pathology-gene fusion and H&E-gene contrastive learning.
-
The relationship to prior histology-to-gene-expression methods is insufficiently discussed. The manuscript mainly lists several prediction baselines but does not clearly position MoSPR relative to different methodological paradigms in this area.
-
The figure quality is insufficient. Several figures are difficult to read because of low resolution and small visual elements, which significantly affects presentation quality.
-
The methodological novelty of the low-rank molecular prediction component is limited. Projecting high-dimensional and strongly correlated gene-expression targets into a low-dimensional space before regression is a natural and widely used strategy.
-
The actual methodological novelty should be stated more narrowly. The most distinctive part seems to be the construction of cohort-level adjacency-informed morphology macrostates, rather than the overall low-rank regression framework.
3 comments
Response to Reviewer TZSr (2/3): Presentation and related work
Q1. The manuscript suffers from substantial writing and presentation issues. Overall, it reads more like a quickly assembled technical report than a carefully polished conference paper. The abstract is poorly balanced. Roughly two-thirds of the abstract is devoted to experimental results, while the motivation, research problem, and core methodological idea receive comparatively limited explanation. The introduction lacks a clear problem-driven narrative. It should better explain why H&E-to-bulk gene expression prediction is important, what the key challenges are, and where existing methods fall short, rather than mainly presenting a sequential description of the proposed pipeline. The introduction is overly technical for its purpose. As a computational pathology paper, the introduction should emphasize motivation, challenges, intuition, and introducing detailed mathematical formulations at this stage unnecessarily hurts readability. The overall readability is weak. Many sections are written in a technical-report style, with insufficient high-level explanation and transitions between methodological components.
We thank the reviewer for this detailed and constructive feedback on presentation, and we agree with these points. We have rewritten the Abstract so that it focuses on the motivation, the research problem, and the core idea of MoSPR, with the results summarized in two sentences. We have also rewritten the opening of the Introduction around a problem-driven narrative: why predicting gene expression from H&E slides is useful, what makes it difficult (heterogeneous tissue, thousands of correlated genes, and paired cohorts of only hundreds of patients), and why existing methods are data-hungry in this setting. We have also restated our contributions more concisely. We agree that the remaining technical description in the Introduction should be simplified, and that the Methods section needs more high-level explanation and transitions between components. We will address both in a future revision.
Q2. Equation (20) is poorly formatted. The block partition of the regression matrix would be clearer.
We thank the reviewer for this helpful suggestion. We have rewritten Eq. (20) so that each patient's representation, x_n = [M_n | s_n1 | … | s_nK], and the fitted regression matrix are partitioned into matching blocks. The resulting sum, x_n Wq = M_n W{q,global} + Σ_k s_nk W*_{q,k}, is now shown in the same equation. This makes explicit which block of the regression matrix acts on the global representation and which acts on each macrostate, and it leads directly to the macrostate-level terms in Eq. (21).
Q3. The Related Work section is incomplete. It does not adequately review the broader literature on H&E and bulk gene expression, including works on multimodal pathology-gene fusion and H&E-gene contrastive learning.
We thank the reviewer for pointing this out, and we agree that the Related Work section did not adequately cover the broader literature on histology and gene expression. We have revised it to include both lines of work the reviewer mentions. Multimodal pathology–gene fusion methods, such as MMP (Song et al., 2024b), take both histology and genomic profiles as inputs, typically to predict clinical outcomes such as survival. H&E–gene contrastive methods, such as TANGLE (Jaume et al., 2024), use paired bulk expression as a training signal to learn slide representations, which are then used for slide-level tasks such as classification and retrieval. In both cases, expression serves as an input or a training signal, whereas in MoSPR it is the prediction target, inferred from histology alone. These approaches are therefore complementary to ours; for example, slide representations learned by contrastive pretraining could serve as input features to MoSPR.
Response to Reviewer TZSr (3/3): Positioning, figures, and contribution scope
Q4. The relationship to prior histology-to-gene-expression methods is insufficiently discussed. The manuscript mainly lists several prediction baselines but does not clearly position MoSPR relative to different methodological paradigms in this area.
We thank the reviewer for this comment and agree that the previous Related Work section listed methods rather than positioning MoSPR among methodological paradigms. We have reorganized it around how each approach obtains its slide representation.
Most existing histology-to-expression methods learn how to aggregate each slide's patches from slide-level expression labels. They either predict expression per tile and pool the predictions (HE2RNA, MOSBY), or use attention-, transformer- or clustering-based aggregation (AbReg, tRNAformer, SEQUOIA). General WSI aggregators such as ABMIL, TransMIL and Mamba-based models follow the same principle, and graph-based models such as Patch-GCN additionally learn spatial interactions within each patient's patch graph. As described in our response to W1, learning both aggregation and spatial modeling from slide-level labels makes these models parameter-heavy relative to the hundreds of patients typically available. CPNN takes a different route by structuring the output, reconstructing expression from single-cell-derived cell-type prototypes with image-predicted proportions.
MoSPR is closest to unsupervised prototype-based slide representations, which summarize each slide over a set of morphological prototypes without labels. For example, PANTHER (Song et al., 2024a) fits a Gaussian mixture to each slide's patch embeddings and uses its parameters as the slide representation. Within this family, MoSPR differs in three ways:
- Its tissue states are defined once at the cohort level by how often morphologies occur next to each other, so spatial context is captured across the cohort rather than through patient-specific graphs.
- Each state is represented by its deviation from the slide average.
- The only supervised component is a single linear map onto a low-rank expression basis.
This positioning is now stated explicitly in the revised Related Work section.
Q5. The figure quality is insufficient. Several figures are difficult to read because of low resolution and small visual elements, which significantly affects presentation quality.
We thank the reviewer for this comment and agree that several figures are difficult to read in their current form. In a future revision, we will regenerate all figures at higher resolution, preferably in vector format, and enlarge text, labels and other visual elements so that they remain legible at the printed size.
Q6. The methodological novelty of the low-rank molecular prediction component is limited. Projecting high-dimensional and strongly correlated gene-expression targets into a low-dimensional space before regression is a natural and widely used strategy.
We thank the reviewer and agree, as discussed in our response to W2. Projecting correlated expression targets onto a low-dimensional basis before regression is a standard reduced-rank strategy. We have therefore revised the manuscript so that this component is no longer presented as a methodological contribution, and the contributions no longer list it separately.
Q7. The actual methodological novelty should be stated more narrowly. The most distinctive part seems to be the construction of cohort-level adjacency-informed morphology macrostates, rather than the overall low-rank regression framework.
We thank the reviewer for this assessment, with which we agree. The cohort-level, adjacency-informed macrostate dictionary is the most distinctive part of MoSPR, and we have revised the contributions accordingly. The first contribution is now this cohort-level representation, in which all patients are described over a shared dictionary of morpho-spatial tissue states learned once from the training cohort without supervision. The remaining points, data-efficient prediction and a lightweight model, are presented as properties that follow from this design rather than as separate methodological contributions.
Response to Reviewer TZSr (1/3): Methodological novelty
We thank the reviewer for the candid and detailed critique, which has been very helpful in identifying weaknesses in our presentation and clarifying the scope of our methodological contributions.
W1. The methodological novelty appears limited and should be positioned more carefully. Most individual components of MoSPR are well-established techniques: frozen pathology foundation-model features, k-means-based morphology prototypes, spatial patch adjacency, diffusion-map/spectral clustering, PCA-based dimensionality reduction, and ridge regression.
We thank the reviewer for this comment, and we agree that each component of MoSPR is well established. Our intention was not to introduce a new learning algorithm, but to assemble these components into a design suited to a specific setting: predicting thousands of correlated genes from whole-slide images when paired histology–transcriptomic cohorts contain only hundreds of patients.
The central design choice is to describe all patients in one shared frame of reference rather than learning a representation for each patient. MoSPR first builds, without supervision, a single cohort-level vocabulary of recurring tissue states. Every slide is then summarized by the abundance of each state and by how that state's morphology departs from the slide average. Because this structure is fixed before supervision, the only part learned from expression labels is a single linear map onto a low-rank expression basis.
We chose this design to address three practical limitations of patient-specific approaches such as MIL, Transformer- and graph-based models:
We have revised the Introduction to state this design rationale explicitly and to position MoSPR more carefully relative to existing prototype- and graph-based approaches.
W2. The low-rank molecular component is largely standard PCA regression. The second major contribution claimed by the paper is a “training-derived low-rank expression basis”. However, the proposed procedure consists of fitting PCA to the standardized gene-expression matrix, regressing histology features onto the PCA coefficients using ridge regression, and reconstructing the output through the PCA basis.
We thank the reviewer for this accurate description, and we agree that the low-rank component is a standard PCA-based (reduced-rank) regression. We have revised the manuscript so that it is no longer presented as a separate methodological contribution, but as a deliberate design choice within the overall framework.
Its role follows from the setting described in our response to W1. When thousands of strongly correlated genes must be predicted from only hundreds of patients, restricting the output to the main directions of variation in the training expression matrix regularizes the regression and stabilizes estimation. Within MoSPR, this choice is beneficial: with the same inputs, predicting low-rank coefficients instead of each gene directly improved gene-level SCC on BRCA, both for the global representation (0.348 → 0.380) and for the full MoSPR representation (0.395 → 0.411; Table 3).
At the same time, the low-rank output alone does not explain MoSPR's performance. When we applied the same low-rank output to two representative baselines, either by retraining them on the low-rank targets or by projecting their predictions onto the same basis, they remained well below MoSPR in all three cohorts (Table S4; e.g., BRCA: ABMIL 0.354–0.380 and tRNAformer 0.327–0.338 vs MoSPR 0.411). The benefit therefore arises from combining a compact, linear state-structured representation with a low-rank output, rather than from the low-rank regression itself. We now state this explicitly and refer to the PCA components as a low-rank expression basis rather than as molecular programs.